Milestone Pharmaceuticals Inc
MIST
Company Profile
Business description
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Contact
1111 Dr. Frederik-Phillips Boulevard
Suite 420
MontrealQCH4M 2X6
CANT: +1 514 336-0444
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
38
Stocks News & Analysis
stocks
6 undervalued US shares that crushed earnings
Atlassian and CarMax remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks
Undervalued REIT offers attractive yield post earnings
Resilient income, attractive yield for Aussie REIT.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,289.30 | 20.70 | 0.22% |
| CAC 40 | 8,579.60 | 57.19 | -0.66% |
| DAX 40 | 26,338.61 | 101.70 | -0.38% |
| Dow JONES (US) | 53,459.78 | 272.63 | -0.51% |
| FTSE 100 | 10,720.30 | 29.81 | -0.28% |
| HKSE | 25,291.14 | 162.09 | -0.64% |
| NASDAQ | 26,644.91 | 84.25 | -0.32% |
| Nikkei 225 | 67,925.33 | 1,294.92 | -1.87% |
| NZX 50 Index | 13,814.47 | 92.49 | 0.67% |
| S&P 500 | 7,745.06 | 40.70 | -0.52% |
| S&P/ASX 200 | 9,085.20 | 20.40 | 0.23% |
| SSE Composite Index | 3,966.99 | 15.66 | -0.39% |